CBRN Funding Activities

 
Group by: Business Activity:
Date:
 


   [-] 2011:
NumberTitleThreat AreasActionAnnouncedClose
BARDA-CBRN-10-100-SOL-00012 ARA290 Hematopoietic Radiological Even/Exposure
 Contract Awarded to Araim Sep 2011  
BARDA-CBRN-10-100-SOL-00012 Noval antimicrobials Broad Spectrum Antibiotics
 Contract Awarded to GSK Sep 2011  
BARDA-CBRN-10-100-SOL-00012 Monoclonal IM Formulation Anthrax Antitoxins
 Contract Awarded to Elusys Sep 2011  
BARDA-CBRN-10-100-SOL-00012 Somatostatin-like Radiological Even/Exposure
 Contract Awarded to Univ. of Arkansas Sep 2011  
BARDA-CBRN-10-100-SOL-00012 nano-DTPA oral forumulation Radiological Even/Exposure
 Contract Awarded to Nanotherapeutics Sep 2011  
BARDA-CBRN-10-100-SOL-00012 Adeno based rPA Anthrax Vaccines
 Contract Awarded to Vaxin Sep 2011  
BARDA-CBRN-10-100-SOL-00012 GI ARS LPA therapeutic Radiological Even/Exposure
 Contract Awarded to RXBIO Sep 2011  
BARDA-CBRN-10-100-SOL-00012 HemaMax (rhuIL-12) Radiological Even/Exposure
 Contract Awarded to Neumedicines Aug 2011  
BARDA-BAA-09-100-SOL-00010 Multiplexed Flu Immunity Assay Innovation
 Contract Awarded to MesoScale Aug 2011  
BARDA-CBRN-10-100-SOL-00012 Intranasal Amyl Nitrate (for cyanide) Chemical Threats
 Contract Awarded to Southwest Research Inst. Aug 2011  
BARDA-CBRN-10-100-SOL-00012 In vivo electron paramagnetic resonance system Biodosimetry
 Contract Awarded to Dartmouth Aug 2011  
BARDA-CBRN-10-100-SOL-00012 Galantamine (for volatile nerve agents) Chemical Threats
 Contract Awarded to Countervail Corp Aug 2011  
BARDA-CBRN-BAA-09-34 ABC294640 for GI ARS Acute Radiation Syndrome
 Contract Awarded to Apogee Jul 2011  
BARDA-CBRN-10-100-SOL-00012 AVX-470 for GI ARS Acute Radiation Syndrome
 Contract Awarded to Avaxia Jul 2011  
BARDA-CBRN-10-100-SOL-00012 Label Comprehension Study Broad Spectrum Antibiotics
 Contract Awarded to SNBL Jul 2011  
BARDA-CBRN-10-100-SOL-00012 BIO-300 Acute Radiation Syndrome
 Contract Awarded to Humanetics Corporation Jun 2011  
RFP-BARDA-10-100-SOL-00025 Animal Model Development IDIQ Biological, Chemical, RAD/NUC Threats
 Contract Awarded to IDIQ: Base Contracts Awarded to 12 Vendors May 2011  
BARDA-CBRN-BAA-11-100-SOL-00009 BARDA-CBRN-BAA-11-100-SOL-00009 Biodefense
 Feb 2011 Mar 2012
BARDA-CBRN-10-100-SOL-00012 Lung MCM Angiotensis II Radiological Even/Exposure
 Contract Awarded to US Biotest Feb 2011  
RFP-11-100-SOL-00007 ST-246 Development and delivery of 1.7M treatment courses to the SNS Smallpox
 Contract Awarded to SIGA for $433,000,000.00 Feb 2011  
RFP-BARDA-10-101 Pediatric Formulation for Prussian Blue Radiological Even/Exposure
 Contract Awarded to Heyltex Feb 2011  
BARDA-CBRN-10-100-SOL-00012 Smallpox Antiviral Smallpox
 Contract Awarded to Chimerix Feb 2011  
BARDA-CBRN-10-100-SOL-00012 Skin MCM Antioxidant Chemical Pulmonary Agents
 Contract Awarded to Aeolus Feb 2011  
   [-] 2010:
NumberTitleThreat AreasActionAnnouncedClose
BARDA-CBRN-10-100-SOL-00012 LC16m8 Vaccine Research Smallpox
 Contract Awarded to Kaketsuken Dec 2010  
BARDA-CBRN-BAA-09-100-SOL-0010 Innovation: Rapid Sterility Testing Platform for Vaccines Biodefense
 Contract Awarded to Rapid Sep 2010  
BARDA-CBRN-BAA-09-100-SOL-0010 Innovation: Synthetic Influenza Vaccine Seeds for Rapid Response Biodefense
 Contract Awarded to Novartis Sep 2010  
BARDA-CBRN-BAA-09-100-SOL-0010 Innovation: Rapid Screening Platform Mass Tag PCR Biodefense
 Contract Awarded to Northrop Grumman Sep 2010  
11-100-SOL-00021 Next Generation Portable Ventilators Flu/Respiratory
 Contract Awarded to Newport Medical Instruments Sep 2010  
BARDA-CBRN-BAA-10-100-SOL-00012 rPA (Recombinant Protective Antigen) Anthrax
 Contract Awarded to Emergent Biosolutions Sep 2010  
BARDA-CBRN-09-100-SOL-00005 Adult Stem Cell Therapy for Neutropenia Radiological Even/Exposure
 Contract Awarded to Cellerant Therapeutics Aug 2010  
BARDA-CBRN-BAA-09-34 New Aminoglycoside Broad Spectrum Antibiotics
 Contract Awarded to Achaogen Aug 2010  
BARDA-CBRN-BAA-09-100-SOL-0010 Innovation: in vitro immunity assay development Biodefense
 Contract Awarded to Vax Design Jul 2010  
BARDA-CBRN-BAA-09-100-SOL-0010 Innovation: rPA Vaccine Development Biodefense
 Contract Awarded to Pfenex Jul 2010  
BARDA-CBRN-BAA-09-100-SOL-0010 Innovation: Cavvine Stabilization Biodefense
 Contract Awarded to PATH Jul 2010  
BARDA-CBRN-BAA-09-100-SOL-0010 Innovation: Adjevant Development Biodefense
 Contract Awarded to IDRI Jul 2010  
BARDA-CBRN-BAA-09-34 AVA Vaccine Expanded Mfg. Capacity Anthrax
 Contract Awarded to Emergent Biosolutions Jul 2010  
11-100-SOL-00021 Respirator Studies Flu/Respiratory
 Contract Awarded to AFFRI Jan 2010  
   [-] 2009:
NumberTitleThreat AreasActionAnnouncedClose
BARDA-CBRN-BAA-09-36 BioDosimetry: Gene Expression Biomarker Panel Biodosimetry
 Contract Awarded to Arizona State University Dec 2009  
BARDA-CBRN-BAA-09-36 BioDosimetry: Gene Expression Biomarker Panel Biodosimetry
 Contract Awarded to Visca Dec 2009  
BARDA-CBRN-BAA-09-36 BioDosimetry: DNA Damage-DNA Fragments in Blood Biodosimetry
 Contract Awarded to University of Rochester Dec 2009  
BARDA-CBRN-BAA-09-36 BioDosimetry: Protein Biomarker Panel Assay Biodosimetry
 Contract Awarded to Stanford University Dec 2009  
BARDA-CBRN-BAA-09-36 BioDosimetry: Protein Biomarker Panel Assay Biodosimetry
 Contract Awarded to SRI Dec 2009  
BARDA-CBRN-BAA-09-36 BioDosimetry: DNA Damage; Micronuclei Biodosimetry
 Contract Awarded to Northrop Grumman Dec 2009  
BARDA-CBRN-BAA-09-36 BioDosimetry: Protein Biomarker Panel Assay Biodosimetry
 Contract Awarded to MesoScale Dec 2009  
BARDA-CBRN-BAA-09-36 BioDosimetry: Breath Test Biodosimetry
 Contract Awarded to Mensanna Dec 2009  
BARDA-CBRN-BAA-09-34 Monoclonal Antibody-ETI-204(Anthim) Anthrax
 Contract Awarded to Elusys Therapeutics Dec 2009  
BARDA-CBRN-BAA-09-36 BioDosimetry: Gene Expression Biomarker Panel Biodosimetry
 Contract Awarded to Duke University Dec 2009  
BARDA-CBRN-BAA-09-36 BioDosimetry: Ocular Dosimetry Albumin in AH of Eye Biodosimetry
 Contract Awarded to Chromologic Dec 2009  
BARDA-CBRN-BAA-09-34 MVA Enhancement Program: Development of a Lyophilized Formulation Smallpox
 Contract Awarded to Bavarian Nordic Nov 2009  
RFP-2004-N01385 Acquisition of Therapeutic Products for the Strategic National Stockpile Anthrax
 Contract Awarded to Human Genome Sciences for $167,000,000.00 Jul 2009  
BARDA-BAA-09-100-SOL-00010 Science and Technology Platforms Applied to Medical Countermeasure (MCM) Development Biodefense
 Jul 2009 Jan 2010
RFI-BARDA-09-38 Generating and Stockpiling Hyperimmune Plasma Against Botulinum Neurotoxin Botulism
 Jun 2009  
BARDA-09-100-SOL-00005 Advanced Therapeutics for Treating Neutropenia Resulting from Acute Exposure to Ionizing Radiation Acute Radiation Syndrome
 Mar 2009 May 2009
RFP-BARDA-09-35 Smallpox Antiviral for the Strategic National Stockpile Smallpox
 Mar 2009 May 2009
BAA-BARDA-09-34 BARDA Broad Agency Announcement for the Advanced Research and Development of Chemical, Biological, Radiological, and Nuclear Medical Countermeasures Biodefense
 Mar 2009 Nov 2009
BAA-BARDA-09-36 Point of Care or High-Throughput Biological Assays for Determining Absorbed Ionizing Radiation Dose (Biodosimetry) After Radiologic and Nuclear Events Biodosimetry
 Feb 2009 Apr 2009
HHS-BARDA-09-33 Advanced Development of Therapeutics for Neutropenia Resulting from Acute Exposure to Ionizing Radiation Acute Radiation Syndrome
 Feb 2009 Sep 2009
BAA-BARDA-09-33 BARDA Broad Agency Announcement for the Advanced Research and Development of Chemical, Biological, Radiological, and Nuclear Medical Countermeasures Biodefense
 Feb 2009  
HHS-BARDA-08-10 Advanced Therapeutics for Treating Neutropenia Resulting from Acute Exposure to Ionizing Radiation Acute Radiation Syndrome
 Jan 2009  
   [-] 2008:
NumberTitleThreat AreasActionAnnouncedClose
RFP-DHHS-BARDA-08-26 Anthrax Vaccine Adsorbed for the Strategic National Stockpile (SNS) Anthrax
 Contract Awarded to Emergent Biodefense Operations for $404,685,512.00 Sep 2008  
BAA-NIH-BARDA-NIAID-DMID-AI2007007 Biodefense Vaccine Enhancement Biodefense
 Contract Awarded to Emergent BioSolutions for $13,072,863.00 Sep 2008  
BAA-BARDA-08-08 Therapies for Hematopoietic Syndrome, Bone Marrow Stromal Cell Loss and Vascular Injury Resulting From Acute Exposure to Ionizing Radiation Acute Radiation Syndrome
 Contract Awarded to Cleveland BioLabs, Inc. for $3,378,767.00 Sep 2008  
BAA-BARDA-08-08 Therapies for Hematopoietic Syndrome, Bone Marrow Stromal Cell Loss and Vascular Injury Resulting From Acute Exposure to Ionizing Radiation Acute Radiation Syndrome
 Contract Awarded to Cellerant Therapeutics, Inc. for $3,361,352.00 Sep 2008  
BAA-BARDA-08-08 Therapies for Hematopoietic Syndrome, Bone Marrow Stromal Cell Loss and Vascular Injury Resulting From Acute Exposure to Ionizing Radiation Acute Radiation Syndrome
 Contract Awarded to Board of Trustees of the University of Illinois for $350,432.00 Sep 2008  
BAA-BARDA-08-08 Therapies for Hematopoietic Syndrome, Bone Marrow Stromal Cell Loss and Vascular Injury Resulting From Acute Exposure to Ionizing Radiation Acute Radiation Syndrome
 Contract Awarded to University of Rochester for $3,174,668.00 Sep 2008  
BAA-BARDA-08-08 Therapies for Hematopoietic Syndrome, Bone Marrow Stromal Cell Loss and Vascular Injury Resulting From Acute Exposure to Ionizing Radiation Acute Radiation Syndrome
 Contract Awarded to University of Pittsburgh for $2,725,629.00 Sep 2008  
BAA-BARDA-08-08 Therapies for Hematopoietic Syndrome, Bone Marrow Stromal Cell Loss and Vascular Injury Resulting From Acute Exposure to Ionizing Radiation Acute Radiation Syndrome
 Contract Awarded to Neumedicines, Inc. for $3,085,185.00 Sep 2008  
BAA-BARDA-08-08 Therapies for Hematopoietic Syndrome, Bone Marrow Stromal Cell Loss and Vascular Injury Resulting From Acute Exposure to Ionizing Radiation Acute Radiation Syndrome
 Contract Awarded to Fred Hutchinson Cancer Research Center for $3,029,574.00 Sep 2008  
BAA-NIH-NIAID-DMID-08-20 Development of Therapeutic Agents for Select Biodefense Pathogens Anthrax
 Contract Awarded to Emergent Biosolutions, Inc. for $24,300,000.00 Sep 2008  
RFP-DHIHS-BARDA-08-26 Anthrax Vaccine Absorbed for the Strategic National Stockpile (SNS) Anthrax
 Aug 2008  
RFI-BARDA-08-21A Physical and Biological Dosimetry Techniques and Devices Useful in Initial Triage After Radiologic and Nuclear Events Biodosimetry
 May 2008 Jul 2008
HHSN266200600014C NDA-Enabling Development for ST-246: A Smallpox Antiviral Drug Smallpox
 Contract Awarded to SIGA Technologies for $15,874,019.00 Apr 2008  
SS-HHS-BARDA-08-99 Emergency Responder Anthrax Antimicrobial Kits Anthrax
 Mar 2008 Mar 2008
RFP-BARDA-08-15 recombinant Protective Antigen (rPA) anthrax vaccine for the strategic national stockpile Anthrax
 Feb 2008 May 2008
HHS-BARDA-08-01-SB recombinant protective antigen (rPA) anthrax vaccine for the Strategic National Stockpile Anthrax
 Feb 2008 Feb 2008
RFP-BARDA-08-12 Medkits Anthrax
 Jan 2008 Feb 2008
   [-] 2007:
NumberTitleThreat AreasActionAnnouncedClose
RFA-AI-07-037 BARDA/NIAID Medical Countermeasures to Mitigate and/or Treat Ionizing Radiation-Induced Cutaneous Injury: Project Bioshield Acute Radiation Syndrome
 Dec 2007 Oct 2009
RFA-AI-07-040 BARDA/NIAID Medical Countermeasures to Mitigate and/or Treat Ionizing Radiation-Induced Pulmonary Injury: Project Bioshield Acute Radiation Syndrome
 Dec 2007 Mar 2008
BAA-NIH-NIAID-DMID-07-06 Development of Therapeutic Agents for Select Biodefense Pathogens Anthrax
 Contract Awarded to Elusys Therapeutics for $11,900,000.00 Oct 2007  
BAA-NIH-NIAID-DMID-07-06 Development of Therapeutic Agents for Select Biodefense Pathogens Anthrax
 Contract Awarded to PharmAthene, Inc. for $13,900,000.00 Oct 2007  
BAA-NIH-NIAID-DMID-07-06 Development of Therapeutic Agents for Select Biodefense Pathogens Anthrax
 Contract Awarded to Emergent Biosolutions, Inc for $9,500,000.00 Oct 2007  
OPHEMC-V&B-07-02 AVA for the SNS Anthrax
 Contract Awarded to Emergent Biodefense Operations for $447,650,001.00 Sep 2007  
BAA-NIH-BARDA-NIAID-DMID-AI2007003 Advanced Development of Multivalent Filovirus (Ebola and Marburg) Hemorrhagic Fever Vaccines Viral hemorrhagic fevers
 Sep 2007 Sep 2009
RFP-DHHS-ORDC-VB-05-06 Draft RFP for Acquisition of Modified Vaccinia Ankara (MVA) Vaccine for the Strategic National Stockpile Smallpox
 Contract Awarded to Bavarian Nordic for $500,000,000.00 Jun 2007  
DHHS-SOURCES-SOUGHT-ARS-MAY-2007 Therapeutics Applicable for the Treatment of Neutropenia Resulting from Exposure to Ionizing Radiation Acute Radiation Syndrome
 May 2007 Jun 2007
SS-DHHS-BARDA-07-01 Anthrax recombinant Protective Antigen (rPA) vaccine for the Strategic National Stockpile (SNS) Anthrax
 May 2007 Jun 2007
RFP-DHHS-OPHEMC-VB-07-02 Anthrax Vaccine Adsorbed for the Strategic National Stockpile (SNS) Anthrax
 Apr 2007 Jun 2007
DHHS-ORDC-DDA-05-12 Medical Countermeasures to Mitigate and/or Treat Neutropenia Alone or in combination with Co-Morbidities Associated with Acute Radiation Syndrome (ARS) Acute Radiation Syndrome
 Mar 2007  
   [-] 2006:
NumberTitleThreat AreasActionAnnouncedClose
RFP-DHHS-ORDC-04-01 Acquisition of rPA Anthrax Vaccine for the Strategic National Stockpile Anthrax
 Contract with VaxGen, Inc. Terminated Dec 2006  
RFP-2004-NO1385 Acquisition of Therapeutic Products for the Strategic National Stockpile Anthrax
 Contract Awarded to Human Genome Sciences for $172,616,980.00 Jun 2006  
2004-N-01183 DHHS and CDC has a requirement for 200,000 Doses of Heptavalent Botulinum Immune Globulin Botulism
 Contract Awarded to Cangene Corporation for $415,080,155.00 Jun 2006  
200-2005-11811-01 Purchase of Additional Anthrax Vaccine Adsorbed (AVA) Anthrax
 Contract Awarded to Bioport for $125,000,000.00 May 2006  
Pediatric Formulation of KI Chronic Effects of Radiation Exposure
 Contract Awarded to Flemming & Co for $10,200,000.00 Feb 2006  
   [-] 2005:
NumberTitleThreat AreasActionAnnouncedClose
RFP-DHHS-ORDC-DDA-05-10 Acquisition of Ca DTPA and Zn DTPA (Calcium and Zinc Diethylenetriaminepentaacetate) to support a public health emergency response to a radiological or nuclear event Chronic Effects of Radiation Exposure
 Contract Awarded to Akorn, Inc for $21,930,000.00 Dec 2005  
200-2005-11811-01 Purchase of Additional Anthrax Vaccine Absorbed (AVA) Anthrax
 Nov 2005  
2004-N-01385 Acquisition of Therapeutic Products for Treatment of Inhalational Anthrax Disease for the Strategic National Stockpile Anthrax
 Contract Awarded to Human Genome Sciences for $1,797,372.00 Oct 2005  
2004-N-01385 Acquisition of Therapeutic Products for Treatment of Inhalational Anthrax Disease for the Strategic National Stockpile Anthrax
 Contract Awarded to Cangene Corporation for $422,880.00 Oct 2005  
RFP-DHHS-ORDC-V and B-05-06 Acquisition of MVA Vaccine for the Strategic National Stockpile (SNS) Smallpox
 Jun 2005 Aug 2005
RFI-ORDC-05-01A Therapeutics to Treat Neutropenia and Thrombocytopenia Associated with the Acute Radiation Syndrome (ARS) Acute Radiation Syndrome
 May 2005 Nov 2005
2005-B-01696 Purchase of BioThrax(TM) Anthrax
 Contract Awarded to BioPort Corporation for $122,737,000.00 May 2005  
DHHS-ORDC-05-01 Pediatric Formulation Potassium Iodide (KI) for the Strategic National Stockpile Chronic Effects of Radiation Exposure
 Contract Awarded to Flemming & Co. for $17,629,003.00 Mar 2005  
RFI-ORDC-05-04 Anthrax Therapeutics Anthrax
 Feb 2005 Apr 2005
   [-] 2004:
NumberTitleThreat AreasActionAnnouncedClose
DHHS-ORDC-05-01 Pediatric Formulation (Liquid) Potassium Iodide (KI) Chronic Effects of Radiation Exposure
 Dec 2004  
RFI-ORDC-05-01 Request for Information (RFI) ORDC-05-01 for Therapeutics to Treat Neutropenia and Thrombocytopenia Associated with the Acute Radiation Syndrome (ARS) Acute Radiation Syndrome
 Oct 2004 Dec 2004
2004-N-01385 Acquisition of Therapeutic Products for Treatment of Inhalational Anthrax Disease for the Strategic National Stockpile Anthrax
 Aug 2004 Aug 2006
RFP-DHHS-ORDC-04-01 Acquisition of Licensed Anthrax Recombinant Protective Antigen (rPA) Vaccine for the Strategic National Stockpile (SNS) Anthrax
 Feb 2004 Apr 2004
   [-] 2003:
NumberTitleThreat AreasActionAnnouncedClose
RFI-ORDC-03-01 Large-Scale Manufacturing Capabilities for Next Generation Anthrax Vaccines (e.g., Anthrax Recombinant Protective Antigen) and Safer Attenuated Vaccinia Vaccines Anthrax
 Aug 2003 Sep 2003